When we talk about GE HealthCare (GEHC), it's natural to want to understand where its stock is heading. It’s not just about a ticker symbol; it’s about the pulse of a company that plays such a crucial role in our health.
Looking at the recent data, GEHC's stock has been trading in a range, with figures like a 52-week high around $93.25 and a low near $57.54. As of mid-February 2026, the stock price hovered around the $80-$84 mark, showing some fluctuations. For instance, on February 13th, it closed at $80.34, with a slight uptick in after-hours trading. Then, by February 20th, it had moved to $84.23. This kind of movement isn't uncommon in the market, and it often reflects a mix of company performance, industry trends, and broader economic factors.
Digging a bit deeper, we see key financial indicators. The Price-to-Earnings (P/E) ratio, a common metric for valuing stocks, has been around 17.66 to 18.51 TTM (Trailing Twelve Months). This gives us a sense of how much investors are willing to pay for each dollar of earnings. The market capitalization, which represents the total value of the company's outstanding shares, has been in the range of $36.6 billion to $38.4 billion. These are substantial figures, underscoring GEHC's position in the market.
What about dividends? GEHC does pay a dividend, with a recent yield around 4.59% to 5.82% TTM, and the dividend per share noted at $0.14 TTM. This can be an attractive feature for investors looking for income from their investments. The company also has a history of recent dividend payments, with specific ex-dividend and payment dates noted, like January 9th, 2026, and February 13th, 2026, respectively.
Beyond the raw numbers, market sentiment plays a significant role. Analyst ratings offer a glimpse into how professionals view the stock. Across various recent updates in February 2026, a strong majority of analysts recommend a 'Buy' for GEHC, with percentages often around 57% to 61.5%. A substantial portion also hold a 'Hold' rating, while a smaller percentage suggest 'Sell'. The price targets provided by these analysts offer a range, with averages often falling in the $93.25 area, and highs reaching up to $105.00 or even $126.00 in some forecasts.
Order flow data, which tracks the movement of money into and out of the stock, can also be insightful. We see periods of net inflow and outflow, with different sizes of orders (large, medium, small) contributing to these movements. For example, on February 13th, there was a net inflow of $1535.19 million, with a significant portion coming from medium and small orders. This kind of detail can sometimes hint at underlying investor confidence or caution.
Ultimately, understanding GE HealthCare's stock involves looking at a blend of its financial health, market performance, and the collective opinion of analysts. It’s a dynamic picture, and staying informed about these various facets can help paint a clearer view of the company's trajectory.
